CTSO

Cytosorbents Corporation (CTSO) ESG Analysis Analysis (2026)

Invetso Score: 5.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

CTSO’s R&D intensity supports a modestly better environmental profile than peers by enabling product innovation, though it does not materially reduce operational footprint.

The company’s asset-light capital structure likely limits direct emissions exposure versus manufacturing-heavy peers, but no disclosed sustainability metrics confirm superior environmental management.

Negative leverage values in the provided metrics indicate low debt burden, which can reduce financing pressure for environmental capex relative to more leveraged peers.

Absent disclosed emissions, energy, or waste data, CTSO’s environmental positioning remains harder to verify than peers with formal reporting, limiting confidence in relative strength.

Social

Score:

CTSO’s elevated R&D spend versus revenue suggests a stronger employee skill and innovation base than peers, which can support retention and product quality.

Stock-based compensation at 7.7% of revenue indicates meaningful alignment incentives, but it also implies dilution pressure that may be less favorable than peers with lower equity usage.

No disclosed workforce, safety, or community metrics are provided, so CTSO cannot be assessed as clearly stronger than peers on core social risk management.

As a smaller healthcare technology company, CTSO likely faces lower labor-intensity risk than industrial peers, but the absence of third-party social disclosures keeps its relative position only moderate.

Governance

Score:

Low leverage suggests conservative balance-sheet governance relative to more indebted peers, reducing creditor pressure and refinancing risk.

Stock-based compensation remains material, which can align management incentives but may also signal weaker shareholder dilution discipline than peers with tighter pay structures.

The provided metrics do not show governance red flags, yet they also do not evidence superior board oversight, disclosure quality, or capital allocation discipline.

Without filing-based evidence on board independence, audit controls, or controversies, CTSO’s governance profile appears broadly average versus peers.

Overall Score

Score:

CTSO’s ESG positioning is broadly average versus peers, with modest support from low leverage and R&D intensity but limited disclosure depth across all three pillars.

Score Driver: Limited ESG Disclosure And Lack Of Verified Sustainability Metrics Constrain Relative Positioning Versus Better-Reported Peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Cytosorbents Corporation. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →